[KTTA] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[KTTA] Pasithea Therapeutics Corp.
Announcement Date
18-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -109.62%
YoY- -10,800.00%
Quarter Report
KTTA's Result
KTTA's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 14 14 15 0 0 0 0 -
PBT -2,658 -1,574 630 -1,526 -728 -550 -48 1363.53%
Tax -843 -1,616 0 0 0 0 0 -
NP -1,815 41 630 -1,526 -728 -550 -48 1034.08%
Tax Rate - - -0.00% - - - - -
Total Cost 1,829 -28 -615 1,526 728 550 48 1039.92%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -13,364.21 302.78 4,183.53 0.00 0.00 0.00 0.00 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.08 0.00 0.06 -0.17 -0.07 -0.04 -0.13 -27.71%
EPS Diluted -0.08 0.00 0.06 -0.17 -0.07 -0.04 -0.13 -27.71%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.